About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

StemCell Institute(7096) Financial Results

7096
TSE Growth
StemCell Institute
1,239
JPY
-4
(-0.32%)
Dec 23, 3:30 pm JST
7.91
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 ＊ 1,409 86 92 62 6.4 0 Jun 25, 2021 J-GAAP
Mar, 2022 1,781 226 212 133 13.2 0 May 12, 2022 J-GAAP
Mar, 2023 2,091 297 300 198 19.3 0 May 11, 2023 J-GAAP
Mar, 2024 2,481 413 417 310 30.4 0 May 14, 2024 J-GAAP
Mar, 2025 Guidance 3,000 600 600 500 48.8 25 May 14, 2024 J-GAAP
YoY +20.9% +45.3% +43.9% +61.3% +60.8%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 2,481 413 417 310 30.4
Fiscal Year Mar, 2024 Mar, 2024 Mar, 2024 Mar, 2024 Mar, 2024
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 916 116 117 73 7.3 0 May 12, 2022 J-GAAP
Oct - Mar, 2022 1,055 134 136 88 8.6 0 May 11, 2023 J-GAAP
Oct - Mar, 2023 1,268 198 201 151 14.8 0 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 1,627 342 336 229 22.4 0 Nov 12, 2024 J-GAAP
YoY +28.3% +72.7% +67.2% +51.7% +51.2%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 226 873 469 404 644 3,510 67.31 J-GAAP
Mar, 2023 297 -186 99 -285 0 3,324 57.20 J-GAAP
Mar, 2024 413 -477 334 -811 -1 2,845 43.48 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 1,036 163 164 110 10.8 54.7 Nov 8, 2022 J-GAAP
Apr - Sep, 2023 1,213 215 216 159 15.6 51.8 Nov 8, 2023 J-GAAP
Apr - Sep, 2024 1,373 258 264 271 26.5 44.0 Nov 12, 2024 J-GAAP
YoY +13.2% +20.0% +22.2% +70.4% +70.2%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 543 98 99 62 6.1 18.0 Feb 7, 2023 J-GAAP
Jan - Mar, 2023 512 36 37 26 2.5 7.0 May 11, 2023 J-GAAP
Apr - Jun, 2023 577 88 90 75 7.4 15.3 Aug 8, 2023 J-GAAP
Jul - Sep, 2023 636 127 126 84 8.2 20.0 Nov 8, 2023 J-GAAP
Oct - Dec, 2023 671 141 142 95 9.3 21.0 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 597 57 59 56 5.5 9.5 May 14, 2024 J-GAAP
Apr - Jun, 2024 678 123 124 178 17.4 18.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 695 135 140 93 9.1 19.4 Nov 12, 2024 J-GAAP
YoY +9.3% +6.3% +11.1% +10.7% +10.6%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 695 141 142 178 17.4
Fiscal Year Sep, 2024 Dec, 2023 Dec, 2023 Jun, 2024 Jun, 2024
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 410.67 40.3 5,215 2,103 809 ー May 12, 2022 J-GAAP
Mar, 2023 224.33 39.5 5,811 2,298 1,007 0.00 May 11, 2023 J-GAAP
Mar, 2024 262.78 41.1 6,543 2,692 1,318 ー May 14, 2024 J-GAAP
Apr - Sep, 2024 ー 41.4 6,935 2,870 1,590 ー Nov 12, 2024 J-GAAP